Market Research Reports

Healthcare Contract Research Outsourcing Market (Contract Research Organizations, Clinical Data Management, Clinical Trial Laboratories, Regulatory Medical Writing, Academic Medical Center) - Global Industry Analysis, Size, Share, Trends And Forecast 2012 - 2018

94pages
Published Date: 2013-01-17
 

Description





This report covers the market revenue for the global healthcare contract research outsourcing market. A detailed analysis of the market trends, current scenarios and future trends is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analyses trend analysis, and market attractiveness analysis. 

The market is segmented on the basis of services offered into: Clinical trials, regulatory services, medical writing services, clinical data management services. A detailed trend analysis of all the segments with a market evaluation in terms of revenue generated with respect to the applications and geography is available in this report. The market is segmented on the basis of the outsourcing destination research groups including Contract Research Organizations (CROs), Clinical Trial Laboratories (CTL), and Academic Medical Centers (AMCs) 

The report also segments healthcare contract research outsourcing market based on geography into: North America, Europe, Asia and the rest of the world.

A competitive analysis of the market players involved is covered in the report. Some of the major players of this market include: Quintiles, Covance, PPD, Parexel, CRL, Icon, Plc. Medidata Solutions, InVentiv Health, Theorem Clinical research and others. Company overview, financial overview, business strategies, SWOT analysis, recent developments and product portfolio for each of the market player is also highlighted in the report.

The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the Contract research outsourcing market as below:

  • Global healthcare contract research outsourcing market by services
    • Clinical trial services
    • Drug discovery
    • Preclinical studies
  • Phase IV trial (Post marketing surveillance) services
    • Regulatory services
    • Medical writing services
    • Clinical data management (CDM) services
    • Regulatory services
    • Medical writing services
    • Clinical data management (CDM) services
  • Global healthcare contract research outsourcing market by destination research groups
    • Contract Research Organizations (CROs)
    • Clinical Trial Laboratories
    • Academic Medical Centers (AMCs)
  • Global healthcare contract research outsourcing market by Geography
    • North America
    • Europe
    • Asia
    • RoW

Table of Contents




TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 REPORT DESCRIPTION
1.2 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS
3.1 OVERVIEW
3.2 MARKET DRIVERS
      3.2.1 INCREASING COST AND REDUCING PRODUCTIVITY
      3.2.2 PATENT EXPIRATIONS
      3.2.3 DECREASING NEW DRUGS RESEARCH AND DEVELOPMENT (R&D)
      3.2.4 EMERGENCE OF BIOLOGICAL THERAPIES AS THE NEXT GENERATION TREATMENT OPTION
      3.2.5 GLOBALIZATION OF DRUG DEVELOPMENT PROCESS
3.3 MARKET RESTRAINTS
      3.3.1 VARIATION IN REGULATORY GUIDELINES AND APPROVAL PROCESS IN DIFFERENT COUNTRIES
      3.3.2 QUALITY ISSUES
      3.3.3 GENETIC AND DISEASE PROFILE VARIATIONS
      3.3.4 UNFORESEEN COSTS
      3.3.5 DATA CONFIDENTIALITY ISSUES
      3.3.6 RELIABILITY AND SERVICE OUTAGES
3.4 MARKET OPPORTUNITIES
      3.4.1 INCREASING CLINICAL TRIALS IN EMERGING COUNTRIES
      3.4.2 INCREASING OUTSOURCING OF REGULATORY, CLINICAL DATA MANAGEMENT AND MEDICAL WRITING ACTIVITIES

CHAPTER 4 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES
4.1 OVERVIEW
4.2 CLINICAL TRIAL SERVICES
      4.2.1 DRUG DISCOVERY SERVICES
      4.2.2 PRECLINICAL SERVICES
      4.2.3 PHASE I TRIAL SERVICES
      4.2.4 PHASE II TRIAL SERVICES
      4.2.5 PHASE III TRIAL SERVICES
      4.2.6 PHASE IV TRIAL (POST MARKETING SURVEILLANCE) SERVICES
4.3 REGULATORY SERVICES
4.4 MEDICAL WRITING SERVICES
4.5 CLINICAL DATA MANAGEMENT (CDM) SERVICES
4.6 OTHERS

CHAPTER 5 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING, BY DESTINATION RESEARCH GROUPS
5.1 OVERVIEW
5.2 CONTRACT RESEARCH ORGANIZATIONS (CROS)
      5.2.1 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
5.3 CLINICAL TRIAL LABORATORIES (CTL)
      5.3.1 GLOBAL CLINICAL TRIAL LABORATORIES OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
5.4 ACADEMIC MEDICAL CENTERS (AMCS)
      5.4.1 GLOBAL ACADEMIC MEDICAL CENTERS OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)

CHAPTER 6 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY GEOGRAPHY
6.1 OVERVIEW
6.2 NORTH AMERICA
      6.2.1 HEALTHCARE CONTRACT RESEARCH  OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
      6.2.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
      6.2.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
6.3 EUROPE
      6.3.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
      6.3.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
      6.3.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
6.4 ASIA
      6.4.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
      6.4.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
      6.4.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
6.5 REST OF WORLD
      6.5.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
      6.5.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
      6.5.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)

CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 OVERVIEW
7.2 MARKET SHARE BY KEY PLAYERS
7.3 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
      7.3.1 EXPANDING RESEARCH SERVICE CAPABILITIES
      7.3.2 COST EFFECTIVE BUSINESS MODELS
      7.3.3 ABSORBING SKILLED RESEARCH PERSONNEL

CHAPTER 8 RECOMMENDATIONS
8.1 MARKET STRATEGY FOR SUCCESS
8.2 BARRIERS TO BE CONSIDERED

CHAPTER 9 COMPANY PROFILES
9.1 QUINTILES TRANSNATIONAL CORPORATION
      9.1.1 COMPANY OVERVIEW
      9.1.2 FINANCIAL INFORMATION
      9.1.3 BUSINESS STRATEGIES
              9.1.3.1 Expansion of services
              9.1.3.2 Acquisitions and partnerships
              9.1.3.3 Innovation in services offered
      9.1.4 PRODUCT PORTFOLIO
      9.1.5 RECENT DEVELOPMENTS
9.2 COVANCE, INC.
      9.2.1 OVERVIEW
      9.2.2 FINANCIAL INFORMATION
      9.2.3 BUSINESS STRATEGIES
              9.2.3.1 New product development and innovation
              9.2.3.2 Agreements and collaborations
      9.2.4 PRODUCT PORTFOLIO
      9.2.5 RECENT DEVELOPMENTS
9.3 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPD)
      9.3.1 COMPANY OVERVIEW
      9.3.2 FINANCIAL INFORMATION
      9.3.3 BUSINESS STRATEGIES
              9.3.3.1 New product launch and innovation
              9.3.3.2 Expanding geographic presence
      9.3.4 PRODUCT PORTFOLIO
      9.3.5 RECENT DEVELOPMENTS
9.4 PAREXEL INTERNATIONAL CORPORATION
      9.4.1 COMPANY OVERVIEW
      9.4.2 FINANCIAL INFORMATION
      9.4.3 BUSINESS STRATEGIES
              9.4.3.1 Strong presence in Asia and emerging markets
              9.4.3.2 Strategic alliances
      9.4.4 PRODUCT PORTFOLIO
      9.4.5 RECENT DEVELOPMENTS
9.5 CHARLES RIVER LABORATORIES INTERNATIONAL INC. (CRL)
      9.5.1 COMPANY OVERVIEW
      9.5.2 FINANCIAL INFORMATION
      9.5.3 BUSINESS STRATEGIES
              9.5.3.1 Business expansion in APAC region
              9.5.3.2 Expansion of services offered
              9.5.3.3 New product launches and Innovation;
      9.5.4 PRODUCT PORTFOLIO
      9.5.5 RECENT DEVELOPMENTS
9.6 ICON, PLC
      9.6.1 COMPANY OVERVIEW
      9.6.2 FINANCIAL INFORMATION
      9.6.3 BUSINESS STRATEGY
              9.6.3.1 Business expansion in APAC region
              9.6.3.2 Expansion of services offered
              9.6.3.3 New product launches and Innovation
      9.6.4 PRODUCT PORTFOLIO
      9.6.5 RECENT DEVELOPMENTS
9.7 MEDIDATA SOLUTIONS, INC.
      9.7.1 COMPANY OVERVIEW
      9.7.2 FINANCIAL INFORMATION
      9.7.3 BUSINESS STRATEGY
              9.7.3.1 New product launches and Innovation
              9.7.3.2 Focus on emerging economies
              9.7.3.3 Well defined services and initiatives
      9.7.4 PRODUCT PORTFOLIO
      9.7.5 RECENT DEVELOPMENTS
9.8 INVENTIV HEALTH, INC. (PHARMANET DEVELOPMENT GROUP INC.)
      9.8.1 COMPANY OVERVIEW
      9.8.2 BUSINESS STRATEGY
              9.8.2.1 Expansion through agreements and acquisitions
              9.8.2.2 Rebranding subsidiaries
      9.8.3 PRODUCT PORTFOLIO
      9.8.4 RECENT DEVELOPMENTS
9.9 PIRAMAL LIFE SCIENCES
      9.9.1 COMPANY OVERVIEW
      9.9.2 FINANCIAL INFORMATION
      9.9.3 BUSINESS STRATEGY
              9.9.3.1 Expansion of services offered
      9.9.4 PRODUCT PORTFOLIO
      9.9.5 RECENT DEVELOPMENTS

LIST OF FIGURES 

FIG. 1 GLOBAL CLINICAL TRIAL SERVICES OUTSOURCING  MARKET SHARE, BY                CLINICAL TRIALS, 2011 & 2018
FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, MARKET SHARE, BY GEOGRAPHY, 2011 & 2018
FIG. 3 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 2010 – 2018 (USD BILLION)
FIG. 4 EUROPE CONTRACT RESEARCH OUTSOURCING MARKET, 2010 – 2018 (USD BILLION)
FIG. 5 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 2010 – 2018 (USD BILLION)
FIG. 6 REST OF WORLD HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 2010 – 2018 (USD BILLION)
FIG. 7 GLOBAL CONTRACT RESEARCH OUTSOURCING MARKET, MARKET SHARE BY KEY PLAYERS 2011 (%)
FIG. 8 ANNUAL REVENUE OF QUINTILES TRANSNATIONAL CORPORATION, 2008 – 2011 (USD BILLION)
FIG. 9 ANNUAL REVENUE OF COVANCE, INC., 2009 – 2011 (USD MILLION)
FIG. 10 ANNUAL REVENUE OF PPD, INC., 2008 – 2010 (USD MILLION)
FIG. 11 ANNUAL REVENUE OF PAREXEL INTERNATIONAL CORPORATION, 2009 – 2011 (USD MILLION)
FIG. 12 ANNUAL REVENUE OF CRL, 2009 - 2011   (USD MILLION)
FIG. 13 ANNUAL REVENUE OF ICON, PLC,  2009 - 2011 (USD MILLION)
FIG. 14 ANNUAL REVENUE OF MEDIDATA, 2009 - 2011 (USD MILLION)
FIG. 15 ANNUAL REVENUE OF PIRAMAL LIFE SCIENCES, 2009 - 2011 (USD MILLION)

LIST OF TABLES

TABLE 1 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING      MARKET, BY GEOGRAPHY, 2010-2018(USD BILLION)
TABLE 2 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET REVENUE, BY SERVICES, 2010 – 2018 (USD BILLION)
TABLE 3 GLOBAL CLINICAL TRIAL SERVICES OUTSOURCING MARKET REVENUE, BY TRIALS, 2010 – 2018 (USD BILLION)
TABLE 4 GLOBAL CLINICAL TRIAL OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
TABLE 5 GLOBAL REGULATORY SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
TABLE 6 GLOBAL MEDICAL WRITING SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
TABLE 7 GLOBAL CLINICAL DATA MANAGEMENT OUTSOURCING SERVICES MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
TABLE 8 GLOBAL OTHER SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
TABLE 9 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET REVENUE, BY DESTINATION RESEARCH GROUPS, 2010-2018 (USD BILLION)
TABLE 10 GLOBAL CRO MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
TABLE 11 GLOBAL CLINICAL TRIAL LABORATORIES OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
TABLE 12 GLOBAL ACADEMIC MEDICAL CENTERS OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
TABLE 13 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH  OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
TABLE 14 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
TABLE 15 NORTH AMERICA CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
TABLE 16 EUROPE HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
TABLE 17 EUROPE HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
TABLE 18 EUROPE CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
TABLE 19 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
TABLE 20 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
TABLE 21 ASIA CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
TABLE 22 ROW HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
TABLE 23 ROW HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
TABLE 24 ROW CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)

Enquiry Before Buying




Free Market Analysis




The outsourcing market was earlier characterized by the existence of developed economies as major contributors, driving market growth with technological innovations. This concept has evolved with time, and emerging markets such as China and India have started adopting the outsourcing business model and are becoming attractive destinations for contract research outsourcing. In the recent times, countries from Eastern Europe, Latin America, Africa and East Asia are also increasingly adopting this business model. The overall cost of R&D is around 40% and manufacturing cost is 60% of that of the developing countries. Clinical trials outsourcing market was the largest segment in terms of revenue and was valued at USD 14.21 billion in 2010. 

Since 2005, outsourcing of clinical trials has picked up tremendous pace, drug discovery and preclinical services being the most prominent services provided. Growth in the global contract research outsourcing market is driven by cost savings, globalization of drug development and increased productivity. 

Other factors propelling growth of this market include depleting product pipelines, drugs going off-patent in the near future and falling productivity, especially in the last decade. Expertise available with contract research partners, reduced research process duration, increased cost savings, flexible pricing models and research globalization options are observed as major advantages to the pharmaceutical companies that outsource research processes to contract research units.

Key players in the contract research outsourcing (CRO) market include Quintiles, Covance, PPD, Parexel, CRL, Icon, Plc. Medidata Solutions, InVentiv Health and Theorem Clinical research.

global-clinical-trial-services-outsourcing-market-share-by-clinical-trials-2011-2018

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research